Manifestations of left ventricular dysfunction and arrhythmia in patients with chronic hypoparathyroidism and pseudohypoparathyroidism: a preliminary study

Background Cardiac damage triggered by severe hypocalcemia is well known. However, the role of chronic hypoparathyroidism (HP) and pseudohypoparathyroidism (PHP) in cardiac health is still unclear. We investigated the effect of chronic HP and PHP on cardiac structure and conductive function in patie...

Full description

Saved in:
Bibliographic Details
Published inBMC endocrine disorders Vol. 20; no. 1; pp. 61 - 9
Main Authors Wang, Yabing, He, Kun, Wang, Ou, Lin, Xue, Chen, Sixing, Jiang, Yan, Li, Mei, Xia, Weibo, Xing, Xiaoping
Format Journal Article
LanguageEnglish
Published London BioMed Central 11.05.2020
BioMed Central Ltd
BMC
Subjects
Age
EKG
Online AccessGet full text
ISSN1472-6823
1472-6823
DOI10.1186/s12902-020-0541-6

Cover

Abstract Background Cardiac damage triggered by severe hypocalcemia is well known. However, the role of chronic hypoparathyroidism (HP) and pseudohypoparathyroidism (PHP) in cardiac health is still unclear. We investigated the effect of chronic HP and PHP on cardiac structure and conductive function in patients compiling with treatment. Methods The study included 18 patients with HP and eight with PHP aged 45.4 ± 15.4 and 22.1 ± 6.4 years, respectively with a previously regular follow-up. In addition, 26 age- and sex-matched healthy controls were included. General characteristics and biochemical indices were recorded. Cardiac function and structure were assessed by estimation of myocardial enzymes, B-type natriuretic peptide (BNP), and echocardiography. The 12-lead electrocardiogram and 24-h Holter electrocardiography were performed to evaluate the conductive function. Results Levels of serum calcium in HP and PHP were 2.05 ± 0.16 mmol/L and 2.25 ± 0.19 mmol/L, respectively. The levels of myocardial enzyme and BNP were within the normal range. Adjusting for age at evaluation and body mass index, all M-mode measurements, left ventricular mass (LVM), LVM index (LVMI) and relative wall thickness (RWT) were comparable between patients and controls. Prolongation of corrected QT (QTc) intervals occurred in 52.6% (10/19) of patients, and 6.7% (1/15) of patients manifested more than 100 episodes of supraventricular and ventricular extrasystoles, as well as supraventricular tachycardia. None of the above arrhythmias was related to a severe clinical event. Conclusions From this pilot study, patients diagnosed with HP and PHP and well-controlled serum calcium levels manifested normal cardiac morphology and ventricular function, except for prolonged QTc intervals, and a small percentage of mild arrhythmias needing further investigation.
AbstractList Background Cardiac damage triggered by severe hypocalcemia is well known. However, the role of chronic hypoparathyroidism (HP) and pseudohypoparathyroidism (PHP) in cardiac health is still unclear. We investigated the effect of chronic HP and PHP on cardiac structure and conductive function in patients compiling with treatment. Methods The study included 18 patients with HP and eight with PHP aged 45.4 ± 15.4 and 22.1 ± 6.4 years, respectively with a previously regular follow-up. In addition, 26 age- and sex-matched healthy controls were included. General characteristics and biochemical indices were recorded. Cardiac function and structure were assessed by estimation of myocardial enzymes, B-type natriuretic peptide (BNP), and echocardiography. The 12-lead electrocardiogram and 24-h Holter electrocardiography were performed to evaluate the conductive function. Results Levels of serum calcium in HP and PHP were 2.05 ± 0.16 mmol/L and 2.25 ± 0.19 mmol/L, respectively. The levels of myocardial enzyme and BNP were within the normal range. Adjusting for age at evaluation and body mass index, all M-mode measurements, left ventricular mass (LVM), LVM index (LVMI) and relative wall thickness (RWT) were comparable between patients and controls. Prolongation of corrected QT (QTc) intervals occurred in 52.6% (10/19) of patients, and 6.7% (1/15) of patients manifested more than 100 episodes of supraventricular and ventricular extrasystoles, as well as supraventricular tachycardia. None of the above arrhythmias was related to a severe clinical event. Conclusions From this pilot study, patients diagnosed with HP and PHP and well-controlled serum calcium levels manifested normal cardiac morphology and ventricular function, except for prolonged QTc intervals, and a small percentage of mild arrhythmias needing further investigation.
Background Cardiac damage triggered by severe hypocalcemia is well known. However, the role of chronic hypoparathyroidism (HP) and pseudohypoparathyroidism (PHP) in cardiac health is still unclear. We investigated the effect of chronic HP and PHP on cardiac structure and conductive function in patients compiling with treatment. Methods The study included 18 patients with HP and eight with PHP aged 45.4 ± 15.4 and 22.1 ± 6.4 years, respectively with a previously regular follow-up. In addition, 26 age- and sex-matched healthy controls were included. General characteristics and biochemical indices were recorded. Cardiac function and structure were assessed by estimation of myocardial enzymes, B-type natriuretic peptide (BNP), and echocardiography. The 12-lead electrocardiogram and 24-h Holter electrocardiography were performed to evaluate the conductive function. Results Levels of serum calcium in HP and PHP were 2.05 ± 0.16 mmol/L and 2.25 ± 0.19 mmol/L, respectively. The levels of myocardial enzyme and BNP were within the normal range. Adjusting for age at evaluation and body mass index, all M-mode measurements, left ventricular mass (LVM), LVM index (LVMI) and relative wall thickness (RWT) were comparable between patients and controls. Prolongation of corrected QT (QTc) intervals occurred in 52.6% (10/19) of patients, and 6.7% (1/15) of patients manifested more than 100 episodes of supraventricular and ventricular extrasystoles, as well as supraventricular tachycardia. None of the above arrhythmias was related to a severe clinical event. Conclusions From this pilot study, patients diagnosed with HP and PHP and well-controlled serum calcium levels manifested normal cardiac morphology and ventricular function, except for prolonged QTc intervals, and a small percentage of mild arrhythmias needing further investigation.
Cardiac damage triggered by severe hypocalcemia is well known. However, the role of chronic hypoparathyroidism (HP) and pseudohypoparathyroidism (PHP) in cardiac health is still unclear. We investigated the effect of chronic HP and PHP on cardiac structure and conductive function in patients compiling with treatment. The study included 18 patients with HP and eight with PHP aged 45.4 [+ or -] 15.4 and 22.1 [+ or -] 6.4 years, respectively with a previously regular follow-up. In addition, 26 age- and sex-matched healthy controls were included. General characteristics and biochemical indices were recorded. Cardiac function and structure were assessed by estimation of myocardial enzymes, B-type natriuretic peptide (BNP), and echocardiography. The 12-lead electrocardiogram and 24-h Holter electrocardiography were performed to evaluate the conductive function. Levels of serum calcium in HP and PHP were 2.05 [+ or -] 0.16 mmol/L and 2.25 [+ or -] 0.19 mmol/L, respectively. The levels of myocardial enzyme and BNP were within the normal range. Adjusting for age at evaluation and body mass index, all M-mode measurements, left ventricular mass (LVM), LVM index (LVMI) and relative wall thickness (RWT) were comparable between patients and controls. Prolongation of corrected QT (QTc) intervals occurred in 52.6% (10/19) of patients, and 6.7% (1/15) of patients manifested more than 100 episodes of supraventricular and ventricular extrasystoles, as well as supraventricular tachycardia. None of the above arrhythmias was related to a severe clinical event. From this pilot study, patients diagnosed with HP and PHP and well-controlled serum calcium levels manifested normal cardiac morphology and ventricular function, except for prolonged QTc intervals, and a small percentage of mild arrhythmias needing further investigation.
Cardiac damage triggered by severe hypocalcemia is well known. However, the role of chronic hypoparathyroidism (HP) and pseudohypoparathyroidism (PHP) in cardiac health is still unclear. We investigated the effect of chronic HP and PHP on cardiac structure and conductive function in patients compiling with treatment. The study included 18 patients with HP and eight with PHP aged 45.4 ± 15.4 and 22.1 ± 6.4 years, respectively with a previously regular follow-up. In addition, 26 age- and sex-matched healthy controls were included. General characteristics and biochemical indices were recorded. Cardiac function and structure were assessed by estimation of myocardial enzymes, B-type natriuretic peptide (BNP), and echocardiography. The 12-lead electrocardiogram and 24-h Holter electrocardiography were performed to evaluate the conductive function. Levels of serum calcium in HP and PHP were 2.05 ± 0.16 mmol/L and 2.25 ± 0.19 mmol/L, respectively. The levels of myocardial enzyme and BNP were within the normal range. Adjusting for age at evaluation and body mass index, all M-mode measurements, left ventricular mass (LVM), LVM index (LVMI) and relative wall thickness (RWT) were comparable between patients and controls. Prolongation of corrected QT (QTc) intervals occurred in 52.6% (10/19) of patients, and 6.7% (1/15) of patients manifested more than 100 episodes of supraventricular and ventricular extrasystoles, as well as supraventricular tachycardia. None of the above arrhythmias was related to a severe clinical event. From this pilot study, patients diagnosed with HP and PHP and well-controlled serum calcium levels manifested normal cardiac morphology and ventricular function, except for prolonged QTc intervals, and a small percentage of mild arrhythmias needing further investigation.
Abstract Background Cardiac damage triggered by severe hypocalcemia is well known. However, the role of chronic hypoparathyroidism (HP) and pseudohypoparathyroidism (PHP) in cardiac health is still unclear. We investigated the effect of chronic HP and PHP on cardiac structure and conductive function in patients compiling with treatment. Methods The study included 18 patients with HP and eight with PHP aged 45.4 ± 15.4 and 22.1 ± 6.4 years, respectively with a previously regular follow-up. In addition, 26 age- and sex-matched healthy controls were included. General characteristics and biochemical indices were recorded. Cardiac function and structure were assessed by estimation of myocardial enzymes, B-type natriuretic peptide (BNP), and echocardiography. The 12-lead electrocardiogram and 24-h Holter electrocardiography were performed to evaluate the conductive function. Results Levels of serum calcium in HP and PHP were 2.05 ± 0.16 mmol/L and 2.25 ± 0.19 mmol/L, respectively. The levels of myocardial enzyme and BNP were within the normal range. Adjusting for age at evaluation and body mass index, all M-mode measurements, left ventricular mass (LVM), LVM index (LVMI) and relative wall thickness (RWT) were comparable between patients and controls. Prolongation of corrected QT (QTc) intervals occurred in 52.6% (10/19) of patients, and 6.7% (1/15) of patients manifested more than 100 episodes of supraventricular and ventricular extrasystoles, as well as supraventricular tachycardia. None of the above arrhythmias was related to a severe clinical event. Conclusions From this pilot study, patients diagnosed with HP and PHP and well-controlled serum calcium levels manifested normal cardiac morphology and ventricular function, except for prolonged QTc intervals, and a small percentage of mild arrhythmias needing further investigation.
Background Cardiac damage triggered by severe hypocalcemia is well known. However, the role of chronic hypoparathyroidism (HP) and pseudohypoparathyroidism (PHP) in cardiac health is still unclear. We investigated the effect of chronic HP and PHP on cardiac structure and conductive function in patients compiling with treatment. Methods The study included 18 patients with HP and eight with PHP aged 45.4 [+ or -] 15.4 and 22.1 [+ or -] 6.4 years, respectively with a previously regular follow-up. In addition, 26 age- and sex-matched healthy controls were included. General characteristics and biochemical indices were recorded. Cardiac function and structure were assessed by estimation of myocardial enzymes, B-type natriuretic peptide (BNP), and echocardiography. The 12-lead electrocardiogram and 24-h Holter electrocardiography were performed to evaluate the conductive function. Results Levels of serum calcium in HP and PHP were 2.05 [+ or -] 0.16 mmol/L and 2.25 [+ or -] 0.19 mmol/L, respectively. The levels of myocardial enzyme and BNP were within the normal range. Adjusting for age at evaluation and body mass index, all M-mode measurements, left ventricular mass (LVM), LVM index (LVMI) and relative wall thickness (RWT) were comparable between patients and controls. Prolongation of corrected QT (QTc) intervals occurred in 52.6% (10/19) of patients, and 6.7% (1/15) of patients manifested more than 100 episodes of supraventricular and ventricular extrasystoles, as well as supraventricular tachycardia. None of the above arrhythmias was related to a severe clinical event. Conclusions From this pilot study, patients diagnosed with HP and PHP and well-controlled serum calcium levels manifested normal cardiac morphology and ventricular function, except for prolonged QTc intervals, and a small percentage of mild arrhythmias needing further investigation. Keywords: Hypoparathyroidism, Pseudohypoparathyroidism, Heart, Function, Arrhythmia
Cardiac damage triggered by severe hypocalcemia is well known. However, the role of chronic hypoparathyroidism (HP) and pseudohypoparathyroidism (PHP) in cardiac health is still unclear. We investigated the effect of chronic HP and PHP on cardiac structure and conductive function in patients compiling with treatment.BACKGROUNDCardiac damage triggered by severe hypocalcemia is well known. However, the role of chronic hypoparathyroidism (HP) and pseudohypoparathyroidism (PHP) in cardiac health is still unclear. We investigated the effect of chronic HP and PHP on cardiac structure and conductive function in patients compiling with treatment.The study included 18 patients with HP and eight with PHP aged 45.4 ± 15.4 and 22.1 ± 6.4 years, respectively with a previously regular follow-up. In addition, 26 age- and sex-matched healthy controls were included. General characteristics and biochemical indices were recorded. Cardiac function and structure were assessed by estimation of myocardial enzymes, B-type natriuretic peptide (BNP), and echocardiography. The 12-lead electrocardiogram and 24-h Holter electrocardiography were performed to evaluate the conductive function.METHODSThe study included 18 patients with HP and eight with PHP aged 45.4 ± 15.4 and 22.1 ± 6.4 years, respectively with a previously regular follow-up. In addition, 26 age- and sex-matched healthy controls were included. General characteristics and biochemical indices were recorded. Cardiac function and structure were assessed by estimation of myocardial enzymes, B-type natriuretic peptide (BNP), and echocardiography. The 12-lead electrocardiogram and 24-h Holter electrocardiography were performed to evaluate the conductive function.Levels of serum calcium in HP and PHP were 2.05 ± 0.16 mmol/L and 2.25 ± 0.19 mmol/L, respectively. The levels of myocardial enzyme and BNP were within the normal range. Adjusting for age at evaluation and body mass index, all M-mode measurements, left ventricular mass (LVM), LVM index (LVMI) and relative wall thickness (RWT) were comparable between patients and controls. Prolongation of corrected QT (QTc) intervals occurred in 52.6% (10/19) of patients, and 6.7% (1/15) of patients manifested more than 100 episodes of supraventricular and ventricular extrasystoles, as well as supraventricular tachycardia. None of the above arrhythmias was related to a severe clinical event.RESULTSLevels of serum calcium in HP and PHP were 2.05 ± 0.16 mmol/L and 2.25 ± 0.19 mmol/L, respectively. The levels of myocardial enzyme and BNP were within the normal range. Adjusting for age at evaluation and body mass index, all M-mode measurements, left ventricular mass (LVM), LVM index (LVMI) and relative wall thickness (RWT) were comparable between patients and controls. Prolongation of corrected QT (QTc) intervals occurred in 52.6% (10/19) of patients, and 6.7% (1/15) of patients manifested more than 100 episodes of supraventricular and ventricular extrasystoles, as well as supraventricular tachycardia. None of the above arrhythmias was related to a severe clinical event.From this pilot study, patients diagnosed with HP and PHP and well-controlled serum calcium levels manifested normal cardiac morphology and ventricular function, except for prolonged QTc intervals, and a small percentage of mild arrhythmias needing further investigation.CONCLUSIONSFrom this pilot study, patients diagnosed with HP and PHP and well-controlled serum calcium levels manifested normal cardiac morphology and ventricular function, except for prolonged QTc intervals, and a small percentage of mild arrhythmias needing further investigation.
ArticleNumber 61
Audience Academic
Author Wang, Yabing
Li, Mei
Xing, Xiaoping
He, Kun
Chen, Sixing
Wang, Ou
Lin, Xue
Jiang, Yan
Xia, Weibo
Author_xml – sequence: 1
  givenname: Yabing
  orcidid: 0000-0001-8367-3830
  surname: Wang
  fullname: Wang, Yabing
  organization: Department of Endocrinology, Key Laboratory of Endocrinology of the Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College
– sequence: 2
  givenname: Kun
  surname: He
  fullname: He, Kun
  organization: Department of Internal Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
– sequence: 3
  givenname: Ou
  surname: Wang
  fullname: Wang, Ou
  organization: Department of Endocrinology, Key Laboratory of Endocrinology of the Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College
– sequence: 4
  givenname: Xue
  surname: Lin
  fullname: Lin, Xue
  email: linxuepumch@qq.com
  organization: Department of Cardiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
– sequence: 5
  givenname: Sixing
  surname: Chen
  fullname: Chen, Sixing
  organization: Department of Endocrinology, Key Laboratory of Endocrinology of the Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College
– sequence: 6
  givenname: Yan
  surname: Jiang
  fullname: Jiang, Yan
  organization: Department of Endocrinology, Key Laboratory of Endocrinology of the Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College
– sequence: 7
  givenname: Mei
  surname: Li
  fullname: Li, Mei
  organization: Department of Endocrinology, Key Laboratory of Endocrinology of the Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College
– sequence: 8
  givenname: Weibo
  surname: Xia
  fullname: Xia, Weibo
  organization: Department of Endocrinology, Key Laboratory of Endocrinology of the Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College
– sequence: 9
  givenname: Xiaoping
  surname: Xing
  fullname: Xing, Xiaoping
  email: xingxp2006@126.com
  organization: Department of Endocrinology, Key Laboratory of Endocrinology of the Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32393234$$D View this record in MEDLINE/PubMed
BookMark eNp9kstu3SAURa0qVfNoP6CTCqmTTpwCxmB3UCmK-oiUqpN2jI4BX3Nlgwt2In9Lf7Y4N01y04cthAVrb87B-zg7cN6ZLHtJ8CkhFX8bCa0xzTHFOS4ZyfmT7IgwQXNe0eLgwfdhdhzjFmMiKoqfZYcFLeo02FH28ws425o4wWS9i8i3qDfthK6Mm4JVcw8B6SW2s1MrgMBpBCF0y9QNFpB1aEzKBEd0bacOqS54ZxXqltGPEGDqluCttnG4kY7RzNr_ufkOARqD6e1gHYQFxWnWy_PsaQt9NC9u55Ps-8cP384_55dfP12cn13miuNiyhvFa60aUgrW4Eo3XHBas6YhhhaNaQDKsigryqqK1KRWqmakhlbUWpu2rApdnGQXO1_tYSvHYIdUgvRg5c2CDxsJYbKqN1KAoSAoJm3NWcNKgLpQdVFiLkRJACev9zuvcW4Go9V6jdDvme7vONvJjb-SghKeRjJ4c2sQ_I85_Rg52KhM34Mzfo6SMkwqIhipEvr6Ebr1c3DpqlaKMcIJZvfUBlID1rU-natWU3nGqWDp4Wvdp3-h0qvNYFWKXWvT-p7g1cNG7zr8Ha0EkB2ggo8xmPYOIViu8ZW7-MoUX7nGV_KkEY80yu6Smaqx_X-VdKeM6RS3MeH-Lv4t-gWtHQbC
CitedBy_id crossref_primary_10_1007_s12325_022_02198_y
crossref_primary_10_4103_JICC_JICC_70_20
crossref_primary_10_1002_hsr2_1796
crossref_primary_10_1016_j_radcr_2022_08_092
Cites_doi 10.1111/cen.13895
10.2165/00002018-199921001-00002
10.1161/01.RES.87.7.e10
10.1001/jama.2011.308
10.1002/jcph.679
10.1016/0002-9149(76)90140-5
10.1056/NEJM198501243120401
10.1038/srep22283
10.1161/01.CIR.25.6.947
10.1016/0002-9149(81)90210-1
10.1016/S0002-9440(10)65313-8
10.4070/kcj.2013.43.8.573
10.1136/hrt.2005.067843
10.1016/S0002-9149(99)80412-3
10.1056/NEJM195704182561603
10.1002/clc.4960210319
10.7326/0003-4819-145-4-200608150-00004
10.1002/jbmr.1979
10.1111/cen.12948
10.1210/jc.2011-2218
10.1093/omcr/omu030
10.1016/j.jelectrocard.2012.10.007
10.1016/0002-9343(89)90338-0
10.1016/j.mayocp.2017.05.028
10.1016/j.jacc.2005.08.067
10.1016/j.echo.2014.10.003
10.1007/s10741-013-9371-1
10.1136/bcr-2013-203512
10.2459/JCM.0b013e32835ec53d
ContentType Journal Article
Copyright The Author(s). 2020
COPYRIGHT 2020 BioMed Central Ltd.
2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s). 2020
– notice: COPYRIGHT 2020 BioMed Central Ltd.
– notice: 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QP
7TK
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s12902-020-0541-6
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Calcium & Calcified Tissue Abstracts
Neurosciences Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One
ProQuest Central
Proquest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
Publicly Available Content Database

MEDLINE


MEDLINE - Academic
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 5
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1472-6823
EndPage 9
ExternalDocumentID oai_doaj_org_article_7ae2a7201f964b45aa93c935067751a0
PMC7216721
A627444460
32393234
10_1186_s12902_020_0541_6
Genre Journal Article
GeographicLocations Beijing China
United States--US
GeographicLocations_xml – name: Beijing China
– name: United States--US
GrantInformation_xml – fundername: National Natural Science Foundation of China
  grantid: 81873641; 81670349
  funderid: http://dx.doi.org/10.13039/501100001809
– fundername: National Natural Science Foundation of China
  grantid: 81670349
– fundername: National Natural Science Foundation of China
  grantid: 81873641
– fundername: ;
  grantid: 81873641; 81670349
GroupedDBID ---
0R~
23N
2WC
53G
5VS
6J9
6PF
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CS3
DIK
E3Z
EBD
EBLON
EBS
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
INH
INR
ITC
KQ8
M1P
M48
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
PUEGO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
TR2
TUS
UKHRP
W2D
WOQ
WOW
XSB
~8M
AAYXX
ALIPV
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
3V.
7QP
7TK
7XB
8FK
AZQEC
DWQXO
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c603t-bc69dcb1574b08db676294bb1e23bebaa5535824881919cc9419af79ddef583d3
IEDL.DBID M48
ISSN 1472-6823
IngestDate Wed Aug 27 01:23:21 EDT 2025
Thu Aug 21 13:46:45 EDT 2025
Fri Sep 05 11:15:34 EDT 2025
Fri Jul 25 04:15:31 EDT 2025
Tue Jun 17 21:29:47 EDT 2025
Tue Jun 10 20:49:47 EDT 2025
Thu Apr 03 07:08:24 EDT 2025
Tue Jul 01 01:37:12 EDT 2025
Thu Apr 24 23:01:24 EDT 2025
Sat Sep 06 07:29:46 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Heart
Function
Arrhythmia
Hypoparathyroidism
Pseudohypoparathyroidism
Language English
License Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c603t-bc69dcb1574b08db676294bb1e23bebaa5535824881919cc9419af79ddef583d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-8367-3830
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12902-020-0541-6
PMID 32393234
PQID 2404416104
PQPubID 44656
PageCount 9
ParticipantIDs doaj_primary_oai_doaj_org_article_7ae2a7201f964b45aa93c935067751a0
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7216721
proquest_miscellaneous_2401817418
proquest_journals_2404416104
gale_infotracmisc_A627444460
gale_infotracacademiconefile_A627444460
pubmed_primary_32393234
crossref_primary_10_1186_s12902_020_0541_6
crossref_citationtrail_10_1186_s12902_020_0541_6
springer_journals_10_1186_s12902_020_0541_6
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2020-05-11
PublicationDateYYYYMMDD 2020-05-11
PublicationDate_xml – month: 05
  year: 2020
  text: 2020-05-11
  day: 11
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle BMC endocrine disorders
PublicationTitleAbbrev BMC Endocr Disord
PublicationTitleAlternate BMC Endocr Disord
PublicationYear 2020
Publisher BioMed Central
BioMed Central Ltd
BMC
Publisher_xml – name: BioMed Central
– name: BioMed Central Ltd
– name: BMC
References T Suzuki (541_CR29) 1998; 21
LJ Drop (541_CR27) 1981; 47
RM Lang (541_CR16) 2015; 28
E Rentoukas (541_CR8) 2013; 46
MS Maurer (541_CR26) 1995; 75
L Cakerri (541_CR6) 2014; 2014
L Underbjerg (541_CR11) 2013; 28
D Du Bois (541_CR14) 1989; 5
Y Wang (541_CR17) 2016; 6
HL Kennedy (541_CR25) 1976; 38
F Latif (541_CR3) 2013; 14
RM Sussman (541_CR30) 1957; 256
541_CR15
SM Straus (541_CR20) 2006; 47
P Hingorani (541_CR24) 2016; 56
541_CR19
541_CR7
HL Kennedy (541_CR23) 1985; 312
CM Giachelli (541_CR2) 1999; 154
GA Ng (541_CR21) 2006; 92
L Underbjerg (541_CR12) 2016; 84
CJ Rosen (541_CR13) 2012; 97
S Jono (541_CR1) 2000; 87
SC Palmer (541_CR5) 2011; 305
I Vered (541_CR9) 1989; 86
DB Newman (541_CR18) 2014; 19
H Yarmohammadi (541_CR4) 2017; 92
T Vadiveloo (541_CR10) 2019; 90
541_CR28
RG Hiss (541_CR22) 1962; 25
References_xml – volume: 90
  start-page: 285
  year: 2019
  ident: 541_CR10
  publication-title: Clin Endocrinol
  doi: 10.1111/cen.13895
– ident: 541_CR19
  doi: 10.2165/00002018-199921001-00002
– volume: 87
  start-page: E10
  year: 2000
  ident: 541_CR1
  publication-title: Circ Res
  doi: 10.1161/01.RES.87.7.e10
– volume: 305
  start-page: 1119
  year: 2011
  ident: 541_CR5
  publication-title: JAMA
  doi: 10.1001/jama.2011.308
– volume: 56
  start-page: 885
  year: 2016
  ident: 541_CR24
  publication-title: J Clin Pharmacol
  doi: 10.1002/jcph.679
– volume: 38
  start-page: 141
  year: 1976
  ident: 541_CR25
  publication-title: Am J Cardiol
  doi: 10.1016/0002-9149(76)90140-5
– volume: 312
  start-page: 193
  year: 1985
  ident: 541_CR23
  publication-title: N Engl J Med
  doi: 10.1056/NEJM198501243120401
– volume: 6
  start-page: 22283
  year: 2016
  ident: 541_CR17
  publication-title: Sci Rep
  doi: 10.1038/srep22283
– volume: 25
  start-page: 947
  year: 1962
  ident: 541_CR22
  publication-title: Circulation
  doi: 10.1161/01.CIR.25.6.947
– volume: 47
  start-page: 1041
  year: 1981
  ident: 541_CR27
  publication-title: Am J Cardiol
  doi: 10.1016/0002-9149(81)90210-1
– volume: 154
  start-page: 671
  year: 1999
  ident: 541_CR2
  publication-title: Am J Pathol
  doi: 10.1016/S0002-9440(10)65313-8
– ident: 541_CR7
  doi: 10.4070/kcj.2013.43.8.573
– volume: 92
  start-page: 1707
  year: 2006
  ident: 541_CR21
  publication-title: Heart
  doi: 10.1136/hrt.2005.067843
– volume: 75
  start-page: 788
  year: 1995
  ident: 541_CR26
  publication-title: Am J Cardiol
  doi: 10.1016/S0002-9149(99)80412-3
– volume: 256
  start-page: 734
  year: 1957
  ident: 541_CR30
  publication-title: N Engl J Med
  doi: 10.1056/NEJM195704182561603
– volume: 21
  start-page: 227
  year: 1998
  ident: 541_CR29
  publication-title: Clin Cardiol
  doi: 10.1002/clc.4960210319
– volume: 5
  start-page: 303
  year: 1989
  ident: 541_CR14
  publication-title: Nutrition
– ident: 541_CR15
  doi: 10.7326/0003-4819-145-4-200608150-00004
– volume: 28
  start-page: 2277
  year: 2013
  ident: 541_CR11
  publication-title: J Bone Miner Res
  doi: 10.1002/jbmr.1979
– volume: 84
  start-page: 904
  year: 2016
  ident: 541_CR12
  publication-title: Clin Endocrinol
  doi: 10.1111/cen.12948
– volume: 97
  start-page: 1146
  year: 2012
  ident: 541_CR13
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2011-2218
– volume: 2014
  start-page: 77
  year: 2014
  ident: 541_CR6
  publication-title: Oxf Med Case Reports
  doi: 10.1093/omcr/omu030
– volume: 46
  start-page: 128
  year: 2013
  ident: 541_CR8
  publication-title: J Electrocardiol
  doi: 10.1016/j.jelectrocard.2012.10.007
– volume: 86
  start-page: 413
  year: 1989
  ident: 541_CR9
  publication-title: Am J Med
  doi: 10.1016/0002-9343(89)90338-0
– volume: 92
  start-page: 1479
  year: 2017
  ident: 541_CR4
  publication-title: Mayo Clin Proc
  doi: 10.1016/j.mayocp.2017.05.028
– volume: 47
  start-page: 362
  year: 2006
  ident: 541_CR20
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2005.08.067
– volume: 28
  start-page: 1
  year: 2015
  ident: 541_CR16
  publication-title: J Am Soc Echocardiogr
  doi: 10.1016/j.echo.2014.10.003
– volume: 19
  start-page: 199
  year: 2014
  ident: 541_CR18
  publication-title: Heart Fail Rev
  doi: 10.1007/s10741-013-9371-1
– ident: 541_CR28
  doi: 10.1136/bcr-2013-203512
– volume: 14
  start-page: 410
  year: 2013
  ident: 541_CR3
  publication-title: J Cardiovasc Med (Hagerstown)
  doi: 10.2459/JCM.0b013e32835ec53d
SSID ssj0017820
Score 2.2049098
Snippet Background Cardiac damage triggered by severe hypocalcemia is well known. However, the role of chronic hypoparathyroidism (HP) and pseudohypoparathyroidism...
Cardiac damage triggered by severe hypocalcemia is well known. However, the role of chronic hypoparathyroidism (HP) and pseudohypoparathyroidism (PHP) in...
Background Cardiac damage triggered by severe hypocalcemia is well known. However, the role of chronic hypoparathyroidism (HP) and pseudohypoparathyroidism...
Abstract Background Cardiac damage triggered by severe hypocalcemia is well known. However, the role of chronic hypoparathyroidism (HP) and...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 61
SubjectTerms Adolescent
Adult
Age
Arrhythmia
Arrhythmias, Cardiac - etiology
Arrhythmias, Cardiac - metabolism
Arrhythmias, Cardiac - physiopathology
Atrial Premature Complexes - etiology
Atrial Premature Complexes - metabolism
Atrial Premature Complexes - physiopathology
Basic and Clinical Endocrinology
Body mass index
Brain natriuretic peptide
Calcium
Calcium (blood)
Calcium - metabolism
Cardiac arrhythmia
Cardiac patients
Cardiomyopathy
Cardiovascular disease
Care and treatment
Case-Control Studies
Cholesterol
Chronic Disease
Diabetes
Echocardiography
EKG
Electrocardiography
Electrocardiography, Ambulatory
Endocrinology
Enzymes
Female
Function
Heart
Humans
Hypertension
Hypocalcemia
Hypoparathyroidism
Hypoparathyroidism - complications
Hypoparathyroidism - metabolism
Hypoparathyroidism - physiopathology
Kidney diseases
Laboratories
Long QT Syndrome - etiology
Long QT Syndrome - metabolism
Long QT Syndrome - physiopathology
Male
Medical research
Medicine
Medicine & Public Health
Metabolic Diseases
Middle Aged
Morphology
Natriuretic Peptide, Brain - metabolism
Natriuretic peptides
Parathyroid hormones
Patients
Phosphorus
Pilot Projects
Potassium
Pseudohypoparathyroidism
Pseudohypoparathyroidism - complications
Pseudohypoparathyroidism - metabolism
Pseudohypoparathyroidism - physiopathology
Research Article
rology
Structure-function relationships
Tachycardia
Tachycardia, Supraventricular - etiology
Tachycardia, Supraventricular - metabolism
Tachycardia, Supraventricular - physiopathology
Ventricle
Ventricular Dysfunction, Left - diagnostic imaging
Ventricular Dysfunction, Left - etiology
Ventricular Dysfunction, Left - metabolism
Ventricular Dysfunction, Left - physiopathology
Ventricular Premature Complexes - etiology
Ventricular Premature Complexes - metabolism
Ventricular Premature Complexes - physiopathology
Vitamin D
Vitamin deficiency
Young Adult
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Ni9UwEA-yB_Eiftt1lQiCoJRtmyZtvK3isgjPkwt7C5OP0gdv20fbd-jf4j9rJu17bndRLxZ6aSaQZCYzmcz0N4S8c4JngBtQlprHeeVsDCKTsSuctl4-LDMY0V19FxeX-bcrfnWj1BfmhE3wwNPCnRbgMii8maqkyHXOASQzknFEPuMpBG89kcnemZrjB4gCN8cw01Kc9njbksXoKvkjShqLhRUKYP13VfINm3Q7X_JW0DTYovNH5OF8iKRn0-Afk3uueULur-Yw-VPycwWYstJPYfaethXduGqgmNsYLvygo3bs0aYhAYXGUui6ehzq6zXQdUNnuNWe4j0tNROCLq3HbRuwwuuxa9d23V-Hrtve7Wx7t_ETBbrt3CYUDutGGqBsn5HL868_vlzEcxWG2IiEDbE2QlqjU17kOimtFl59ylzr1GVMOw3AOf5t6xWBd_2kMTJPJVSF9Hqz4iWz7Dk5atrGvSQ05bYsmShl6spcggRTeYeIO8kSA2DKiCR7rigzQ5RjpYyNCq5KKdTESOUZqZCRSkTkw6HLdsLn-BvxZ2T1gRChtcMHL3BqFjj1L4GLyHsUFIUKwA_OwPwfg58iQmmpM6xm5B_hKU8WlH7jmmXzXtTUrDh65Q9YOfqcSR6Rt4dm7InJcI1rd4HGn8sQdigiLybJPEyJIaRdxnzvYiGzizkvW5p1HWDFEcbJvxH5uJfu38P645Ie_48lfUUeZNPejNP0hBwN3c699me9Qb8J2_oXGMhR7w
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ba9swFBZbB2MvY_e664YGg8GGqWVZsrWX0Y2VMsieVsib0M1LILUzO3nwb-mfnY6spHPLGshLdARWzkXn5u8g9N5xlitQQFFplha1s6niuUhd6bT18mGpgYru7Cc_vyh-zNk8Jtz62Fa5s4nBUNvWQI78xN88BTjjWfFl_SeFqVFQXY0jNO6jBwG6zMtzOd8HXASw4GIlk1T8pIecS55CwOQdFZLyyV0UIPtvG-Z_bqabXZM3SqfhRjp7gh5HVxKfjrx_iu655hl6OIvF8ufoaqagcaUfi-09bmu8cvUGQ4djSPupDtuhh5sNCLBqLFZdtxg2i8ulwssGR9DVHkO2FpsRRxcvhnUbEMMXQ9cu7bK_DFvXvdva9vbiZ6zwunOrMD6sG3AAtH2BLs6-__p2nsZZDKnhGd2k2nBhjSasLHRWWc29ERWF1sTlVDutFGPwzq03Bz4AFMaIgghVl8Jbz5pV1NKX6KBpG3eIMGG2qiivBHFVIZRQpvZhEXOCZkYpUyUo23FFmghUDvMyVjIELBWXIyOlZ6QERkqeoI_7LesRpeMu4q_A6j0hAGyHH9rut4z6KkvlclV676gWvNAFU0pQIygDwD1GVJagDyAoEsyAfzij4tsM_ogAqCVPYaaR_3BPeTyh9Oprpss7UZPRfPTyWtgT9G6_DDuhJa5x7TbQeO8MwIcS9GqUzP2RKADb5dTvLicyOznzdKVZLgK4OIA5-W-CPu2k-_qx_vuXHt19iNfoUT5qXUrIMTrYdFv3xvtyG_02KOxf0FJKZQ
  priority: 102
  providerName: ProQuest
– databaseName: Springer Nature OA Free Journals
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3di9QwEA96gvgifl_PUyIIglJsmiZtfDsPj0NYnzy4tzD5KLuw1y7t7sP-Lf6zl0m76_VOBQt9aWYg6cwkM5nJL4S891LkgAaoKiPSovYuBZmr1JfeuKAfjlvM6M5-yPOL4vuluBzBovEszM38Pavk5x73SfIUg5zgXLBU3icPBOMy5mXl6T5hgLBvY9Lyj2yTZSei89-dg28sQrcLJG9lSePic_aEPB69RnoyiPkpueebZ-ThbMyLPye_ZoA1Kv2QV-9pW9Olr9cUixnjDh901G17XMSQgELjKHTdfLueXy2ALho64qv2FDdmqR0gc-l8u2ojOPh827ULt-ivIuuq9xvX3m38QoGuOr-MN4V1Wxqxa1-Qi7NvP0_P0_HahdTKjK9TY6Vy1jBRFiarnJFhvlSFMczn3HgDIAQerw2WH2I9Za0qmIK6VGGirEXFHX9JDpq28YeEMuGqistKMV8VChTYOkRAwiueWQBbJSTbSUXbEZMcr8ZY6hibVFIPgtRBkBoFqWVCPu5ZVgMgx7-Iv6Ko94SIpR0_BBXTo2nqEnwOZXCEaiULUwgAxa3iArH1BIMsIR9QUTRafOichfHgQhgiYmfpE7y-KDwyUB5PKIOl2mnzTtX0OFP0OnhUBQaZWZGQd_tm5MTqt8a3m0gTHDHEGUrIq0Ez90PiiGGX88BdTnR2MuZpS7OYRxxxxG0Kb0I-7bT7d7f--kuP_ov6NXmUD0aYMnZMDtbdxr8JXtzavI32ew3XfELj
  priority: 102
  providerName: Springer Nature
Title Manifestations of left ventricular dysfunction and arrhythmia in patients with chronic hypoparathyroidism and pseudohypoparathyroidism: a preliminary study
URI https://link.springer.com/article/10.1186/s12902-020-0541-6
https://www.ncbi.nlm.nih.gov/pubmed/32393234
https://www.proquest.com/docview/2404416104
https://www.proquest.com/docview/2401817418
https://pubmed.ncbi.nlm.nih.gov/PMC7216721
https://doaj.org/article/7ae2a7201f964b45aa93c935067751a0
Volume 20
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ta9swEBZ9gdIvY-_z1gUNBoMNb36RZGswRhNayiBllAXCvghJlptAamd2AvNv2Z-dTrbTpe32YYEEHJ2w5LvT3enk5xB6bRiNJCggTxX1SW4yX7KI-yYxKrPykcUaMrrjc3Y2IV-mdLqD-vJW3QOs7wztoJ7UpFq8__mj-WwV_pNT-JR9qGEvJfIhELIOSOizXbRvDRODWGxMrpMKAA3XJTbv7HaIDmJABItismWlHJj_7SX7D5t18zzljaSqs1Wn99G9zsnEx61UPEA7pniIDsZdGv0R-jWWcKSlbtPwNS5zvDD5CsPZR7chKCucNTXYPCDAssiwrKpZs5pdzSWeF7iDY60x7ONi3SLs4lmzLB2W-Kypynk2r69c12Vt1ll5u_EjlnhZmYUrLFY12EHdPkaT05NvozO_q9LgaxbEK19pxjOtQpoQFaSZYnZ55USp0ESxMkpKSuFtXLtQ2NCQa81JyGWecLuu5jSNs_gJ2ivKwjxDOKRZmsYs5aFJCZdc6twGTNTwONBS6tRDQc8VoTsIc6iksRAulEmZaHkqLE8F8FQwD73ddFm2-B3_Ih4CqzeEAL3t_iirS9FpskikiWRi_aacM6IIlZLHmscUoPhoKAMPvQFBESCydnBadu852CkC1JY4hmpH9sMs5dEWpVVsvd3ci5ro9UJYB4xATBoQD73aNENPOCxXmHLtaKzfBrBEHnraSuZmSr2AeyjZktmtOW-3FPOZgx0HmCf79dC7Xrqvh_XXR_r8v-_zAh1GrW76YXiE9lbV2ry0DuBKDdBuMk0GaH94cv71wl6N2GjgNlMGTuHt78Xw-29XTWAi
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLZGJwEviDuBAUYCIYGi5WYnRkJog00dWyeENmlvnm-hlbqkJK1Qfgv_gd-Ij5N2ZBN7W6W-1MdVnHN8Lj7H30HotaEkErABWSaJn-RG-4JGzDepkdrKh44VZHRHh3R4nHw9ISdr6M_yLgyUVS51olPUulRwRr5pLU8CzniQfJr99KFrFGRXly00WrHYN80vG7LVH_e-WP6-iaLdnaPPQ7_rKuArGsRzXyrKtJIhSRMZZFpSqw5YImVoolgaKQQhcHvUCrYNZZhSLAmZyFNm9UBOsljH9n9voPUEbrQO0Pr2zuG376u8BaDPdbnTMKObNZzyRD6EaNY1Cn3as36uScBlU_CPLbxYp3khWets4O5ddKdzXvFWK2330Jop7qOboy49_wD9Hgkolanb9H6NyxxPTT7HUFPpDhpFhXVTgy0FAiwKjUVVjZv5-Gwi8KTAHcxrjeF8GKsWuRePm1npMMrHTVVO9KQ-c1NntVno8vLgByzwrDJT17CsarCD0H2Ijq-FT4_QoCgL8wThkOgsi2nGQpMlTDChchuIEcPiQAmhMg8FS65w1UGjQ4eOKXchUkZ5y0huGcmBkZx66N1qyqzFBbmKeBtYvSIESG_3Q1n94J2G4KkwkUitP5YzmsiECMFixWICEH8kFIGH3oKgcFA89uGU6O5P2CUChBffgi5K9kMt5UaP0ioM1R9eihrvFFbNz7eXh16thmEmFOEVplw4GusPAtyRhx63krlaUgxQelFsZ6c9me2tuT9STMYOzhzgo-zXQ--X0n3-WP99pU-vXsRLdGt4NDrgB3uH-8_Q7ajdgX4YbqDBvFqY59aTnMsX3fbF6PS6NcZfllqI_A
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bi9QwFA66wuKLeLe6agRBUMq2zaWNb-vqsF5m8cGFfQu51RmYbYe289Df4p81J-2MdlcFC_PSnAPNnHtO8gWhl46zTIEBikKzmJbOxopnIna509brhyUGOrrzU35yRj-ds_PxntN2u9t925IczjQASlPVHa5tOZh4wQ9bWD3JYih9fMqRxvw6ukEh8kG3lh_v2ggABje2Mv_INglGAbP_qmf-LTRd3jZ5qXcaQtLsNro15pL4aBD-HXTNVXfR_nzslt9DP-YKdq60Q7e9xXWJV67sMGxxDOt-qsG2byG0AQFWlcWqaRZ9t7hYKrys8Ii62mJYrsVmANLFi35dB8jwRd_US7tsLwLrunUbW18dfIsVXjduFe4Pa3ocEG3vo7PZh2_HJ_F4GUNseEK6WBsurNEpy6lOCqu596KCap26jGinlWIMDt16f-ArQGGMoKlQZS68-yxZQSx5gPaqunKPEE6ZLQrCC5G6ggollCl9XcScIIlRyhQRSrZSkWZEKocLM1YyVCwFl4MgpRekBEFKHqHXO5b1ANPxL-J3IOodISBshxd1812OBitz5TKV-_SoFJxqypQSxAjCAHGPpSqJ0CtQFAl-wH-cUeNxBj9FQNSSR3CpkX-4pzyYUHr7NdPhrarJ0X-00udZFErPhEboxW4YOGFPXOXqTaDx6RmgD0Xo4aCZuykRQLbLiOfOJzo7mfN0pFouAro4oDn5X4TebLX712f99S99_F_Uz9H-1_cz-eXj6ecn6GY22GOcpgdor2s27qlP8zr9LJjyT_fnThc
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Manifestations+of+left+ventricular+dysfunction+and+arrhythmia+in+patients+with+chronic+hypoparathyroidism+and+pseudohypoparathyroidism%3A+a+preliminary+study&rft.jtitle=BMC+endocrine+disorders&rft.au=Wang%2C+Yabing&rft.au=He%2C+Kun&rft.au=Wang%2C+Ou&rft.au=Lin%2C+Xue&rft.date=2020-05-11&rft.pub=BioMed+Central&rft.eissn=1472-6823&rft.volume=20&rft_id=info:doi/10.1186%2Fs12902-020-0541-6&rft_id=info%3Apmid%2F32393234&rft.externalDocID=PMC7216721
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1472-6823&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1472-6823&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1472-6823&client=summon